Cell Line Development Market in Europe Will Grow at 12.5% CAGR by 2024: Sartorius, Samsung Biologics, GE Healthcare and Thermo Fisher Scientific, Selexis and Lonza Group
Growing disease burden across the globe is the key factor that will drive cell line development market growth. Rising demand for vaccines and monoclonal antibodies in treatment of cancer, autoimmune diseases and anti-inflammatory disease will fuel demand for cell line cultures. Developments in biotechnology industry, increasing healthcare expenditure coupled with growing adoption of technologically advanced products should accelerate the cell line development industry growth.
View full press release